"I can't imagine a better stock to buy."
Dear Reader,
It happens all the time.
A phone call. A short conversation in the hallway at a conference. An email from an old friend. Or even just a few words over a drink, at a bar or maybe at a wedding.
People know that I'm in the market for information. A certain kind of information.
And it's funny... you might think that means folks are always looking to get something from me.
Nope. More often than not people seek me out to tell me something, to show me the information they have is even better than mine.
Thankfully... people love to talk. Especially about their company's stock. Or a deal they've learned about.
It really does happen all of the time.
But this time is special. This time it wasn't just some anonymous executive, a fellow journalist, or one of my subscribers.
This time it was my oldest friend, someone I've literally known my entire life. He's done extremely well in his career – becoming one of the top executives in a global Fortune 500 company.
He was calling me to follow up on a question I'd asked about his company.
"I don't know why our stock is trading for less than $10... it's crazy. I know what our sales will be. I know how well our products are doing. We're doing great. I don't know everything about investing. But, I can't imagine a better stock to buy than ours."
Of course, I do know stocks.
My name is Porter Stansberry.
As the founder of a major financial publishing company, I've become friends, colleagues, associates and business partners with a vast network of industry insiders.
From the executives of major corporations, to fellow journalists at media outlets like Barron's and Bloomberg...
And because of that access, I've been able to help my readers make a lot of money...
For instance:
 |
I predicted that Fannie Mae and Freddie Mac were going to zero – thanks to some information I got from a fellow journalist and a trader at Fannie Mae. Some of my readers doubled their money on my short position... and I was featured in Alan Abelson's column in Barron's as a result. |
|
I was the first journalist anywhere to predict General Motors, one of the nation's most renown blue-chip companies, would go bankrupt. One of my family's best friends is a GM dealer. I knew he couldn't turn a profit selling cars and I knew that meant lights out for GM, thanks to their huge debt load. |
|
A buddy of mine is a pharmaceutical CEO... after a late-night phone call from him, I recommended a stock called Elan... It went up 207%. |
|
My good friend is a famous gold-coin trader (he invented the rating system). His tip on a rare coin company helped my readers more than double their money. |
|
Another of my contacts in the medical business tipped me off to a company named Celgene... Readers made 233%. |
|
A friend of mine used to work as an editor for the Tribune Co. and outlined just how bad the newspaper business was... Our newspaper short brought back 60% in just three months. |
But the information my best friend just gave me could be worth much, much more.
I'm confident his stock will be my best play of 2009.
I'm talking about a potential 200%-300%... in just a few short months...
I was on vacation last month when my phone rang...
It was my oldest friend in the world... And over the next 20 minutes we talked about all the key areas of his business – sales, profit, mergers.
There was a lot to discuss, because this is a huge company.
His company commands 50% of the $4 billion worldwide market for heart stents.
And now, they're introducing a new, one-of-a-kind stent technology that needs very little drugs to protect the stent, therefore making it safer and far more effective when implanted in patients.
The final tests are being done on the stent before it's ready to hit the market.
But, when it does, analysts believe it will "become the leading player in the wave of next-generation stents" according to the Wall Street Journal.
My friend didn't have to tell me what would happen next. The last couple of times something like this happened in their company, their stock soared.
That gain came after the company purchased an angioplasty technology where catheters reopen clogged arteries in lieu of surgery. Shares shot up 220% in just over a year.
But look at what happened the last time they released a proprietary stent technology to the market:
Shares soared 411% in three years... That's the same situation we could be looking at today.
I knew the situation at this company was interesting...
And my friend helped me put together all of the pieces.
So later that night, I logged onto Bloomberg.
What I found there blew me away...
Yes, the company's numbers backed up what my friend had to say. The stock was cheap. And not only that, it booked $5.6 BILLION in profits last year – during the worst recession in decades.
I can't ever recall seeing such a high-quality, non-cyclical business trading at such a cheap price.
|
Plus, President Obama is throwing money at will into the healthcare industry, from Big Pharma to hospitals... over $15 billion this year alone.
Health care and medical breakthroughs are a great investment, even in a recession. People will always get sick. They'll always need operations and pills and life-saving devices.
And now, thanks to President Obama, the government's going to pay for it.
But here's what sealed the deal...
You might know of a man named John Paulson. Paulson is one of the most successful private investors in the world.
It's widely believed on the Street that his hedge fund made something in the neighborhood of $20 BILLION over the past two years – even as the market tanked in '08.
That's more money than anyone else – including legends like Warren Buffett and Bill Gross.
What's Paulson buying now?
How about $800 MILLION worth of my friend's company.
He knows that when companies develop breakthrough medical technologies, they can rise fast.
Look at some examples:
- Celgene developed a breakthrough cancer drug called Revlimid that eliminated symptoms in a previously uncurable bone marrow condition. Shares have risen 665% since it was released.
- Immucor's ABS2000 technology was the first FDA-approved device for full automation of blood typing. It completely revolutionized the way blood banks work... and early shareholders have seen gains of nearly 3,000%.
- Questcor's Acthar was one of the first FDA-approved drugs for the treatment of multiple sclerosis... Shares of Questcor went up 2,557 % after Achthar was released.
Over the next two months, I expect to see a gradual rise in this stock, as bits and pieces of the story leak out.
But I don't expect the company to report the full impact of this technology until after a trial run -- probably around October 19th.
And after the 19th?
Well, I think a quick 300% gain is probably a conservative guess.
Let me tell you why...
In December 2002, I got a call from "Rock."
This is a very experienced pharmaceutical executive. He was a Wall Street analyst for decades, then he moved into private money management and ended up on the board of several pharmaceutical companies as the CEO of his own start-up company.
I call him the "Rock" because his offices are in the Rockefeller Center, or "The Rock"" as it's known in New York.
I'd followed the Rock's small start-up in my newsletter for years and we'd become friends.
I was working late one night when the Rock called, out of the blue. He wasn't calling me to talk about his small start up. He was calling to talk about a much larger pharmaceutical business where he served on the board of directors.
This larger company was in trouble. Its stock had fallen to below $2. The rumor was it might go bankrupt. But the Rock told me otherwise. Well, sort of.
What he told me would have been cryptic to most people. All he said was, "If I were you, I'd spend some time looking at this situation... "
Rock didn't tell me the company wasn't going bankrupt. He didn't tell me the stock was definitely going to go up either. He just said, "If I were you, I'd spend some time looking at this situation."
That's all he had to tell me. He knew I could figure out the rest on my own.
You see, the SEC imposes very strict penalties on any company insider who reveals confidential or privileged information to other investors. My sources are well aware of the laws and they're very careful never to break them.
But they don't have to. They know I have enough experience analyzing companies to figure out what they're telling me. I can read between the lines.
So... what happened with the Rock's company... ? The stock went from $2 to $20. A 900% gain.
Many of my readers made a killing.
Like Bob Groening of Indianapolis, IN, who wrote in to say that he remarkably made "more than $1,000,000" with this recommendation.
One subscriber, who works as a financial advisor, Sol Shelby, said some of his clients made, "more than $1 million" on this pick.
And subscriber Brian Kirby of Monmouth Falls, NY, called it one of the " best trades I ever made."
Again, the Rock didn't tell me anything I couldn't find on my own. But, sometimes a nudge in the right direction is all you need to discover a great opportunity.
The same thing is happening with my friend's company and the opportunity is the best I've seen this year. 300% is probably a conservative guess.
If this sounds like something you'd like to get in on, the full details are in my latest special report, "A 300% Promise From My Good Friend."
Here's how to get your free copy...
These kinds of friends are one of the perks of running a successful publishing business. I've worked hard to build it from a single investment advisory newsletter back in 1999 to over a dozen today... with readers all over the world.
In fact, we have over 1 million readers in more than 100 countries... and company executives know it.
In the past, I would publish these tips wherever and whenever I could. But recently I had an idea: Why not create a letter specifically for this kind of information?
And so I did. It's called the Inside Strategist.
Inside Strategist is a weekly advisory newsletter that tracks all the information we receive about what company insiders are doing. And to complete the transition I just hired an exceptionally bright fellow to monitor these situations for me. His name is Braden Copeland.
He's developed a one-of-a-kind database that not only tracks overall insider buying and selling, it tracks it to the day and individual... And it cross-references those transactions with any kind of news on the companies from publications across the country.
In short, if a company insider anywhere in the U.S. makes a move (legally), we know about it immediately. And we match up that information with my network of sources.
Of course, the most important thing is, how do we do for our readers?
In 2008, the stock market was down 37%... our portfolio looked like this:
- 100% on Chesapeake Energy
- 100% on Williams Companies
- 64% on Regions Financial (in just 6 days)
- 100% on Smithfield Foods (in just 2 weeks)
And what I consider the best trade of the year, the one my good friend just told me about, could do much, much better.
As I said, the full details are in my special report: "A 300% Promise From My Good Friend."
To get immediate access, I only ask that you take a 30-day trial subscription to the Inside Strategist.
Now, there are several companies you can hire on Wall Street that will track insider buying for you.
The best service we know that does this costs $20,000 a year.
The Inside Strategist doesn't cost nearly that much. In fact, our service costs less than a subscription to the Wall Street Journal.
Plus, thanks to our vast network of contacts, we can do something none of these other firms can do...
Which is access and track information from non-SEC registered industry experts.
One of those non-registered experts happens to be one of the richest and most successful gold traders in the world.
And he's just alerted us to an opportunity to double your money in a matter of days... on one gold stock.
You've never heard of John Doody.
Doody went from being an economics professor at a small college in dreary Massachusetts... to sailing his yacht between his condo in Florida and his vacation pad in St. Bart's.
He went from being nearly penniless after his divorce to making over $5 million just by using a simple strategy he invented for picking gold stocks.
Barron's has profiled John numerous times, saying his strategy works "spectacularly so." He reports that his average return has been 390% for the last decade... even as the S&P 500 dropped 40%.
He knows more about gold mining stocks than anyone in the world. And when he has a great idea, he calls us. We help John publish his newsletter and he helps us get the scoop on gold stocks... It's that simple.
Just the other day, John called us about a tiny gold mining company trading for just $3...
Here's what he said:
No matter what happens to the price of gold, you could easily double your money – in a matter of days – on this play...
John only tracks 75 companies – all of them gold miners.
Some of them are larger, familiar companies with lots of gold produced...
Others are smaller companies waiting for their big breakthrough.
John just found one of those companies poised to break out... And it's all thanks to an insider play.
You see, in order to run a successful gold mining company, you have to go where the gold is. And quite often, that means dealing with all kinds of governments – and all kinds of bureaucratic mess.
Specifically, once you find the gold, the trouble is getting all the permits to begin drilling.
The company John just told us about has a huge gold find in Greece. But (as far as the public knows) they're still waiting for a permit.
But John knows something else...
The president of Aktor, Greece's largest construction firm, owns a huge stake in this tiny gold miner.
Why does that matter?
Well, Aktor is the primary construction, contracting and engineering firm in Greece. They built the Olympic Stadium, an extension to the Athens subway, and the Athens beltway.
In other words, if there's anybody that knows their way around permits, it's their president. He knows how to get one. How to play the game. And I have no doubt he's got some pull on the inside.
Just recently, Aktor's president nearly DOUBLED his stake in this tiny gold firm.
Again, no one can know the future with 100% accuracy. But I doubt this guy would've thrown down nearly $18 million for no reason. John thinks the permit is coming – soon. And when it does, this stock could easily double... overnight.
Then it's off to the races...
Once this company starts pulling gold out of the ground, we're looking at a potential four-bagger... or even more. Just like what happened to Barrick when they started producing from their Goldstrike Mine in Nevada (shares soared 6,500%).
Or when Oxiana started mining its Prominent Hill gold/copper mine in South Australia. (Shares went up 10-fold). We could easily see the same situation here.
And we just put together John's research in a special report called, "A Quick Double (and More) Thanks to the Ultimate Gold Insider."
Inside, we share with you exactly what company John is recommending (and how to buy it), as well as two other gold companies John thinks should see significant gains in the next two years.
If you'd like, I'll give you this report free of charge... To get access, I only ask that you take a 30-day trial subscription to Inside Strategist.
Let me quickly tell you a little more about our trading philosophy – and this letter – so you can decide if it's right for you.
Even before the market tanked – for months and months ahead of time – I warned my readers of the impending disaster...
In February 2007, I wrote that GM was going bankrupt. In November 2007, I warned that the housing collapse was going to bring the economy to its knees.
And in June 2008, the headline on my eponymous investment advisory newsletter was this: "Freddie Mac and Fannie Mae are Going to Zero."
All of this happened, exactly as I said. Barron's even called me "remarkably prescient" for the calls I made.
But the best part was that these quick, sharp collapses created a once-in-a-lifetime opportunity for quick, sharp gains – with virtually no risk.
And anyone who followed my advice saw exactly that...
A Boston reader named Steve Caulfield wrote in to say he made $20,000 riding these stocks to the ground...
Chicago reader Martin Tolker made $200,000...
Chris Landing, from Florida, wrote in to say he made an incredible 1,500%. Another reader made 300%. And still another made 400%... in just 30 days.
Then, with stock prices bouncing around like lottery balls, I figured out a way to skim big, one-day payouts from these movements...
By employing a little-known trading technique I showed my readers how to make:
- $1,000 on Take Two Interactive...
- $1,800 on Yahoo!...
- And $2,100 on MGM...
Many of my readers made even more than that... and some are still using the technique to this day...
- Bernard Handerson of Carmel, IN, now collects an average of $100 a day.
- Harold Welchik of New Brunswick, NJ, has made over $20,000 so far...
- And Randy Bowman of Annapolis, Maryland, tells me he's made a staggering $87,000 since last October.
I have a friend that we'll call PL. PL has over 30 years experience trading for Lehman Brothers and Bank of America. He knows more about options than most people I know.
It was a note from PL that got me looking at the illogically high prices of put options this past fall.
And thanks to PL's tip, my readers had a chance to make a lot of money. In fact, nearly 8 out of every 10 plays I recommended based on this strategy were winners.
But that's just one example...
Back in 2003, my friend Chris Weber tipped me off to a huge distortion between the currency market and China.
Now, Chris isn't just any old investor. He hasn't had a job since he was 16 years old. Instead, he makes great calls on currency trades, one after another.
It's enough to have earned millions of dollars, a house in Monte Carlo and all the freedom in the world.
When Chris talks about the currency market, I listen. After I investigated this tip-off, I put out a special brief called the China Strategy Report.
My readers could have made a killing buying only three stocks – with gains of 91%, 80% and 62%.
As I said before, I get this kind of information all the time.
The opportunity we have developing right now – the chance to see 300% or more gains on a small medical technology company... and the chance to double our money overnight in gold – are just the latest in that long string of tips.
And while I didn't design the Inside Strategist simply to look for these kinds of opportunities, it has become the perfect vehicle...
You can't possibly know everything going on behind the scenes in the market. No individual in the investment world is that connected...
That's where Braden and I (and our network of connections) come in.
Because of my unique position as the founder of a publishing company with subscribers in over 100 countries, I have access to a number of insiders – across different countries, markets and sectors.
And Braden's experience with monitoring large databases, filtering information and his own investment background (he's been involved in a number of million-dollar commercial real estate deals, as well as starting his own music and racing companies) make us a formidable team. We don't miss much.
In the pages of the Inside Strategist we can use these skills to help our readers make money in a number of ways:
Often, our contacts inside various companies will alert us to great buying opportunities ahead – just like the medical technology deal I mentioned earlier – the one that could easily make us 300% or more.We've had a lot of these types of plays recently, like our recent recommendation of Chimera Investment Corporation (CIM), an investor in mortgage securities.
We have a lot of friends with 20, 30, even 50 years of experience investing in their particular fields, whether it's oil exploration or gold mining.
Like my friend John Doody, who just recommended a gold stock he thinks has the best opportunity to soar this year – anywhere from 100% -300% -- no matter what the price of gold does.
Sometimes, we use insiders we don't know to make money by tracking insider buying. We keep track of hundreds of promising companies every week.
But, we don't recommend them until we've seen a firm commitment from management to put their "money where their mouth is" in the company SEC filings.
On March 4th, we wrote:
At some point, the U.S. mortgage market is going to be a great investment opportunity.
But when?
Most people do pay their mortgages – every month, on time. But soaring defaults on the poorly underwritten mortgages (not to mention the deliberately fraudulent ones) have caused financing for mortgage investors to dry up. Prices on even the highest-rated mortgages have plummeted.Lambiase is the CEO of Chimera. He had just ponied up about $300,000 to buy his own stock on the open market. Like clockwork, within a few weeks, the company raised its dividend, reported 50% higher earnings... and watched its stock spike over 30%.
Sooner or later, this forced and panicked selling will produce excellent values. Sooner or later investors who buy the right mortgages at the right prices are going to make a killing.
Matthew Lambiase clearly thinks the time has come.
And we went along for the ride.
Think he knew something the rest of us didn't?
I do.
We recently found another company in a similar situation... They deal with a specific type of investment that most people never consider. In fact, Barron's called these investments, "hidden jewels waiting to be found."
The CEO has amassed over half a million shares. This year alone he's spent over $1.5 million on shares... And get this, he's never sold a share of his company's stock since becoming CEO five years ago.
Clearly, he has a good feeling about the company's future.
I've included all the details in my special report entitled, "Why One Insider Is Loading Up On This Special Investment."
We monitor insider activity on thousands of stocks every day with just one goal in mind: Big, quick gains.
And we put out a new report every week – tips we've heard, big moves being made, and exactly what you can do to take advantage of them. If you're looking for buy-and-hold recommendations, this is not necessarily the letter for you.
That's not to say we don't do our homework... or stand behind the stocks we recommend. What I'm saying is, you have to be prepared to get in and get out quickly, if the situations arise. That's why we publish a report every Wednesday, and send updates as needed.
Do you have to sit at your computer waiting for a "buy" signal?
Absolutely not.
In fact, in some cases, we publish a recommendation with the strict instructions NOT to get in until a certain day. But these are not usually investments you can mull over for a week or two.
And as I mentioned before, we've brought in a real expert on the subject -- Braden Copeland – to guide you through the process.
Here's what our readers have to say:
"Inside Strategist is a steal. I made 101.4% gain on a single trade."How much can you expect to pay for research as potentially profitable as this?
~ Richard Dunbar
"I made 250% and 100% gains on two of your picks!!!"
~ Hal Green
"With Inside Strategist I have already made back the cost of my subscription at least 25 times."
~ Tim Pinkerton
"[Inside Strategist] recommendations have helped me rake in over $100,000 in total gains. I made over 100% on two picks, and doubled my money on three different occasions... "
~ Gerry Winston
Normally, exclusive access to an analyst as connected as Braden would cost you thousands of dollars a year. As well as a portion of the profits you made.
Outside marketers have suggested we sell this research for $20,000 or more, which is what many professional traders charge for this type of service.
In the past, we've charged as much as $1,000 per year.
But as I said before you won't pay nearly that much...
Sign up for the Inside Strategist through this special invitation and you'll pay just $199 for a full year of research and tips.
And within minutes, you'll have full, unfettered access to the Inside Strategist website, where you'll find the complete details on everything I've mentioned in this letter:
| ° | Special Report #1: "A 300% Promise From My Good Friend." This report details my best friend's company... the new technology they're about to unveil... and exactly how you can get in on the action. If you get in now, you could easily make a nice return in a matter of day... and be in line for a 300% gain come the end of the year. |
| ° | Special Report #2: "A Quick Double Thanks to the Ultimate Gold Insider." I'll tell you all about the gold mining stock my friend John Doody tipped us off to. He thinks it has an easy chance to double this year – no matter what the price of gold does. |
| ° | Special Report #3: "Why One Insider is Loading Up On This Special Investment." One insider is loading up on a special type of investment that Barron's calls "hidden jewels waiting to be found." This CEO, whose company deals only with these investments, now owns over $2 million in shares. |
Once you've read over the reports and decided whether or not you'd like to make these plays, take some time to peruse the rest of our work.
It's all there for you to look at – our full archive of special reports and email updates, with all of our past recommendations and current recommended portfolio.
If this looks like something you'd like to be a part of, do nothing. We'll automatically extend your subscription for a full year.
If you decide it's not for you, simply call our toll-free number and cancel before the 30-day trial period is up.
You'll receive a full refund, no questions asked. Even after the 30-day trial period you can still change your mind, and receive a pro-rated refund on the remaining portion of your subscription.
To get started right away, Subscribe Now .
Sincerely,
Porter Stansberry
Founder, Stansberry and Associates Investment Research
P.S. – Remember, the medical company I mentioned at the beginning of this letter is releasing their new technology any day now. When that happens, this stock is likely to start running. If you want to take advantage of my friend's tip, you have to act fast.
You'll get the full details within minutes of signing up.